Fonte: Journal of Clinical Laboratory Analysis. Unidades: FCF, FM
Assuntos: GENÉTICA, TÉCNICAS E PROCEDIMENTOS DE LABORATÓRIO, HIPERCOLESTEROLEMIA
ABNT
SALAZAR, Luís Antônio et al. Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in brazilian patients with primary hypercholesterolemia. Journal of Clinical Laboratory Analysis, v. 14, n. 3, p. 125-131, 2000Tradução . . Disponível em: https://doi.org/10.1002/(sici)1098-2825(2000)14:3%3C125::aid-jcla7%3E3.3.co;2-j. Acesso em: 05 out. 2024.APA
Salazar, L. A., Hirata, M. H., Quintão, E. C. da R., & Hirata, R. D. C. (2000). Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in brazilian patients with primary hypercholesterolemia. Journal of Clinical Laboratory Analysis, 14( 3), 125-131. doi:10.1002/(sici)1098-2825(2000)14:3%3C125::aid-jcla7%3E3.3.co;2-jNLM
Salazar LA, Hirata MH, Quintão EC da R, Hirata RDC. Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in brazilian patients with primary hypercholesterolemia [Internet]. Journal of Clinical Laboratory Analysis. 2000 ; 14( 3): 125-131.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/(sici)1098-2825(2000)14:3%3C125::aid-jcla7%3E3.3.co;2-jVancouver
Salazar LA, Hirata MH, Quintão EC da R, Hirata RDC. Lipid-lowering response of the HMG-CoA reductase inhibitor fluvastatin is influenced by polymorphisms in the low-density lipoprotein receptor gene in brazilian patients with primary hypercholesterolemia [Internet]. Journal of Clinical Laboratory Analysis. 2000 ; 14( 3): 125-131.[citado 2024 out. 05 ] Available from: https://doi.org/10.1002/(sici)1098-2825(2000)14:3%3C125::aid-jcla7%3E3.3.co;2-j